Pulmatrix, Inc.
PULM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001574235
No open-market purchases or sales by Pulmatrix, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $568.7K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Pulmatrix, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Pulmatrix, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Higgins Michael J | Director | – | Jan 30, 2023 | 0 |
| Bazemore Todd | Director | – | Jan 30, 2023 | 0 |
| Batycky Richard P. | Director | – | Jan 30, 2023 | 0 |
| Varadan Anand | Director | – | Jan 30, 2023 | 0 |
| Raad Teofilo David | Chief Executive Officer | – | Jan 30, 2023 | 0 |
| Siegert Michelle | Vice President, Finance | – | Jan 30, 2023 | 0 |
| Cabell Christopher | Director | – | Jan 30, 2023 | 0 |
| Wasilewski Margaret | Chief Medical Officer | – | Jan 30, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.